ResearcherSoongsil UniversityNo recent work listed

Jeongjin Lee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9676-271X; OpenAlex author ID A5101824064. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2022: 2 papers

Papers 2

Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3348/kjr.2022.0277 ↗
Impact of Baseline Muscle Mass and Myosteatosis on the Development of Early Toxicity During First-Line Chemotherapy in Patients With Initially Metastatic Pancr… Last author DOI 10.3389/fonc.2022.878472 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dong Wook Kim · 1 shared paper, 2022 · strength 0.16
- Paper Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.3348/kjr.2022.0277 ↗
Seung Soo Lee · 1 shared paper, 2022 · strength 0.16
- Paper Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.3348/kjr.2022.0277 ↗
Sun In Hong · 1 shared paper, 2022 · strength 0.16
- Paper Impact of Baseline Muscle Mass and Myosteatosis on the Development of Early Toxicity During First-Line Chemotherapy in … DOI 10.3389/fonc.2022.878472 ↗
Changhoon Yoo · 1 shared paper, 2022 · strength 0.16
- Paper Impact of Baseline Muscle Mass and Myosteatosis on the Development of Early Toxicity During First-Line Chemotherapy in … DOI 10.3389/fonc.2022.878472 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.